Stock market anomaly | Junshi Biosciences (01877.HK) surges nearly 35% at the close. The company previously raised over 1 billion for research and development of PD-1/VEGF dual antibodies and more.

According to the Securities Times App, Junshi Biosciences (01877.HK) surged nearly 35% in the final trading session, rising 34.16% to HK$32.28 at the time of writing, with a turnover of HK$1.25 billion.